Evotec SE (EVO) Non Operating Investment Income (2009)

Evotec SE (EVO) reported Non Operating Investment Income of -$62.64 for Q2 2009, down 419.31% sequentially from $19.62 in Q1 2009.

Evotec SE (EVO) Non Operating Investment Income (2009) Analysis & Trends

Evotec SE (EVO) has 1 years of Non Operating Investment Income data on file, last reported at -$62.64 in Q2 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Operating Investment Income (Qtr)
1	Haleon	89.06 Bn	87.19 Bn	-	-
2	Teva Pharmaceutical Industries	35.81 Bn	32.07 Bn	1.97 Bn	-
3	Zoetis	32.50 Bn	30.56 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	27.51 Bn	23.45 Bn	4.39 Bn	-
5	United Therapeutics	23.19 Bn	21.04 Bn	648.10 Mn	-
6	RedHill Biopharma	21.76 Bn	21.76 Bn	-	-
7	Viatris	20.28 Bn	18.47 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.72 Bn	16.40 Bn	800.70 Mn	-
9	Elanco Animal Health	12.56 Bn	12.13 Bn	785.00 Mn	-
10	Evotec SE	345.39 Mn	344.87 Mn	-	-

Download Data